期刊文献+

不同骨量状态的2型糖尿病患者骨密度影响因素分析 被引量:10

Analysis of factors related to bone mineral density in type 2 diabetic patients
下载PDF
导出
摘要 目的观察不同骨量状态的2型糖尿病(T2DM)患者的糖脂代谢、骨代谢生化指标水平,探讨T2DM患者的骨质疏松(OP)相关危险因素。方法选择北京大学人民医院T2DM患者264例(男性133例,女性131例),采用双能X线骨密度仪测定患者腰椎、股骨颈及全髋BMD,按T值不同分为3个亚组:骨密度正常组(T值>-1.0);骨量减少组(-2.5<T值≤-1.0);OP组(T值≤-2.5)。比较3组之间各种生化、骨代谢指标及BMD的差异并进行相关性分析。结果 1OP组的年龄明显大于其余两组,体重及血尿酸水平明显低于其余两组(P均<0.05)。2OP组的血清BALP及TRACP-5b水平明显高于其余两组(P均<0.05)。OP组和骨量减少组的L1-4、股骨颈及全髋BMD均明显低于正常组,尤以OP组下降明显(P均<0.05)。3男性T2DM患者中,OP组的血尿酸明显低于其余两组,而血清TRACP-5b明显高于其余两组(P均<0.05)。女性T2DM患者中,OP组的血清BALP明显高于其余两组(P<0.05)。4在校正性别、年龄及体重等因素影响后,腰椎骨密度与尿酸正相关(r=0.137,P<0.05),与BALP、TRACP-5b负相关(r=-0.281,-0.146,P均<0.05)。股骨颈骨密度与舒张压、BALP、TRACP-5b负相关(r=-0.135,-0.237,-0.136,P均<0.05),全髋骨密度与BALP负相关(r=-0.25,P<0.05)。5Logistic回归分析结果显示:T2DM患者的年龄、BALP、低体重、低血尿酸水平与OP发生有关(P<0.05)。结论年龄、BALP、低体重、低血尿酸水平与T2DM患者发生OP有关。 Obje ctive To study the levels of biochemical index and bone metabolism biochemical markers in patients with type 2diabetes mellitus( T2DM),to analyze their associations with bone mineral density( BMD) and to discuss risk factors for osteoporosis( OP) in T2 DMpatients. Me thods Two hundred and sixty-four patients with T2 DMwere selected,including 133 male cases and 131 female cases. Diabetic patients were divided into 3 subgroups according to BMD T-score,normal BMD group:T-score 〉- 1. 0; osteopenia group:- 2. 5 〈 T score≤- 1. 0; osteoporosis group: T-score ≤- 2. 5. Biochemical index and bone metabolism biochemical markers were measured. BMD was determined by using dual-energy X-ray absorptiometry( DXA).Re sults Body weight and serum uric acid in osteoporosis group were significantly lower than those in the normal BMD group and osteopenia group( all P 〈 0. 05). Serum BALP and TRACP-5b in the osteoporosis group were significantly higher than those in the other two groups( P 〈 0. 05). Compared with the normal BMD group,BMD of lumbar vertebrae,femoral neck and total hip in osteoporosis group and osteopenia group were significantly lower( all P 〈 0. 05). In male T2 DMpatients,serum TRACP-5b in osteoporosis group was significantly higher than that in the normal BMD group and osteopenia group( P 〈 0. 05),while serum uric acid in the osteoporosis group was lower than that in the latter. In female T2 DMpatients,serum BALP in the osteoporosis group was significantly higher than that in the other two groups( P 〈 0. 05). After adjustment for age,sex,BMI and weight,BMD of lumbar vertebrae positively correlated with uric acid( r = 0. 137,P 〈 0. 05),but negatively correlated with BALP,TRACP-5b( r =- 0. 281,- 0. 146,all P 〈 0. 05). The BMD of femoral neck negatively correlated with diastolic pressure,BALP and TRACP-5b( r =-- 0. 135,- 0. 237,- 0. 136,all P 〈 0. 05). The BMD of total hip negatively correlated with BALP( r =- 0. 25,P 〈0. 05). Logistic regression analysis showthat age,BALP,lowweight and lowserum uric acid were correlated with the incidence of OP in T2 DMpatients( P 〈 0. 05). Conclusion Age,BALP,lowbody weight and lowserum uric acid were risk factors for OP in T2 DMpatients.
出处 《中国骨质疏松杂志》 CAS CSCD 北大核心 2016年第10期1283-1287,1297,共6页 Chinese Journal of Osteoporosis
关键词 骨质疏松症 2型糖尿病 骨代谢生化指标 Osteoporosis Type 2 diabetes Bone metabolism biochemical markers
  • 相关文献

参考文献2

二级参考文献41

  • 1刘忠厚.骨质疏松诊断[M].中国现代文艺出版社,2011:596.
  • 2Lee SK, Lorenzo JA. Parathyroid hormone stimulates TRANCE and inhibits esteopmtegerin messenger ribonucleic acid expresion in mutine bone marrow cultures correlation with osteoelast-like cell formation [ J ]. Endocrinology, 1999, 140 : 3552-3561.
  • 3Kidney Disease: Improving Global Outcomes CKDMBDWG. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney international. Supplement 2009, (113) :S1-130.
  • 4Vesper H. Cosman F. Endres DB, et al. Application of biochemical markers of bone turnover in the assessment and monitoring of bone diseases : approved guidelines. ( 2008 ) NCCLS document C48-A. ISBN 1-56238-539-9.
  • 5Kim CJ. Vitamin D dependent rickets Type I [ J]. Korean J Pediatr,2011,54(2) :51-54.
  • 6Naknsato YR, Janckila A J, Halleen JM, et al. Clinical Significance of immunoasays for type-5 tartrate-resistant acid phosphatase[ J]. Clin Chem. 1999,45 (12) :2150-2157.
  • 7Shiga T, Tsuji Y, Fujioka M, et al. Risk factors for hip fracture in Japanese elderly women with osteoporosis: applicability .of biochemical markers in bone turnover[ J]. Geriatr Gerontol Int, 2009, 9(1): 69-74.
  • 8Bauer DC, Garnero P, Harrison SL, et al. Biochemical markers of bone turnover, hip bone loss, and fracture in older men: the MrOS study[J]. J Bone Miner Res, 2009, 24(12) : 2032-8.
  • 9Donescu OS, BattieMc, Videman T, et al. Anthropometrics and Biochemical markers in men. J Clin Densitom,2005 ,8 :222-227.
  • 10Garnero P, Ferreras M, Karsdal MA, et al. The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation[ J]. Bone Miner Res, 2003, 18 : 859- 867.

共引文献156

同被引文献118

引证文献10

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部